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Received March 12, 2013; accepted June 5, 2013AbstractTransesophageal echocardiography (TEE) is not only an invaluable diagnostic tool for cardiac patients, but also is essential for cardiac
monitoring in critically ill patients in cardiac and non-cardiac surgery settings and in the differential diagnosis of unexplained hemodynamic
collapse. The advantage of TEE over transthoracic echocardiography (TTE) is usually clearer images, especially when viewing structures that
are difficult to see transthoracically. TEE is essential in monitoring adult and congenital heart surgery perioperatively. The adequacy of the repair
can be ensured immediately through a review of TEE images directly after surgery. Although TEE is considered to be relatively safe and
noninvasive, TEE-associated complications, such as esophageal laceration, must be taken seriously. Recently, real-time three-dimensional (3D)
TEE imaging has played an important role defining valvular and congenital abnormalities and aiding in operative and percutaneous repair.
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Echocardiography is the most frequently used diagnostic
tool for real-time imaging of cardiac structure and function. In
the last decade, transesophageal echocardiography (TEE) has
become essential in cardiac surgery, and has expanded its role
in other areas of patient care.1e5 TEE is performed by
inserting a probe with a transducer into the esophagus, and
offers superior visualization of posterior cardiac structures,
because of the close proximity of the esophagus to the post-
eromedial heart, without visual interference from the lung and
skeleton. In 1976, Frazin et al6 first introduced the clinical use
of TEE when a modified rigid endoscopic probe with a single
M-mode crystal was used. In 1980, the phased-array ultra-
sound transducer was introduced, and it was later reduced in
size. The process of implementing biplane probes7e9 by using
crystal miniaturization with color Doppler is the standard* Corresponding author. Dr. Shen-Kou Tsai, Cheng Hsin General Hospital,
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probes become available, utilizing mechanical or electronic
rotation of the 180 degree scanning plane.10e13 Remarkable
progress in TEE probe technology has been made in the last 10
years. More recently, real-time three-dimensional (3D) imag-
ing has been available by using a matrix array ultrasound
probe and an appropriate processing system.14 This enables
detailed anatomical assessment of cardiac pathology and
particularly valvular defects.15 Now, TEE is a well-established
and standard diagnostic technique in the operating room,
intensive care unit, and laboratory catheter room.2. Indication of TEE
TEE can reveal new findings that necessitate cross-
checking perioperatively, such as mitral valve (MV) disor-
ders, blood clots or intracardiac masses, dissection of the
aorta, and implanted prosthetic (artificial) heart valves. In
1996, a joint task force of the American Society of Anesthe-
siologists (ASA) and the Society of Cardiovascular Anesthe-
siologists (SCA) published guidelines for the perioperativehinese Medical Association. All rights reserved.
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guidelines, category I indications of perioperative TEE are:
1. Intraoperative evaluation of acute, persistent, and life-
threatening hemodynamic disturbances in which ventric-
ular function and its determinants are uncertain and have
not responded to treatment.
2. Intraoperative use in valve repair.
3. Intraoperative use in congenital heart surgery for most
lesions requiring cardiopulmonary bypass.
4. Intraoperative use in repair of hypertrophic obstructive
cardiomyopathy.
5. Intraoperative use for endocarditis when preoperative
testing was inadequate or extension of infection to peri-
valvular tissue is suspected.
6. Preoperative use in unstable patients who have suspected
thoracic aortic aneurysms, dissection, or disruption that
needs to be evaluated quickly.
7. Intraoperative assessment of aortic valve function in repair of
aortic dissections with possible aortic valve involvement.
8. Intraoperative evaluation of pericardial window procedures.
9. Use in intensive care unit for unstable patients who have
unexplained hemodynamic disturbances, suspected valve
disease, or thromboembolic problems.
3. Contraindications from TEE18,19
1. Esophageal stricture or malignancy.
2. Surgical interposition of the esophagus.
3. Esophageal diverticulum.
4. Cervical spine arthritis with reduced range of motion.
5. Severe thrombocytopenia (<50,000/mL), elevated inter-
national normalized ratio (>4), or prolonged partial
thromboplastin time (>150 seconds).
4. Tomographic views of TEE20
Several tomographic views are commonly used. A com-
plete TEE examination should include imaging of all cardiac
chambers, valves, and great vessels. A standard comprehen-
sive approach to imaging is recommended, but each individual
study should be modified to reflect the specific clinical indi-
cation. Each tomographic view is defined by the transducer
position in the esophagus, which will view the TEE images of
the mid-esophageal view (at the mid-esophageal position)
including four chamber, five chamber, two chamber, short-
axis, long-axis, two caval views (Fig. 1-1), upper esophageal
view (at upper esophageal position) (Fig. 1-2) and transgastric
view at the gastric position (Fig. 1-3).
Current TEE probes allow for both 2D and 3D imaging, as
well M-mode, spectral Doppler, and color Doppler.4.1. 2D echocardiography2D TEE provides tomographic or "thin slice" imaging, with
each tomographic view defined by the transducer position. Thetechnique is used to visualize the actual structures and the real-
time motion of the heart.4.2. 3D echocardiography3D TEE capability has been developed to overcome the
disadvantages of 2D tomography. 3D TEE was first described
in the 1970s, because the acquisition of ECG and respiratory-
gated 2D images, which subsequently required off-line
reconstruction, was very time-consuming. However, the ma-
trix TEE probe, introduced clinically in 2007, can quickly and
easily collect real-time 3D images, enabling the echocardi-
ographer to provide an entire view that contains all pertinent
information and real time images. This in turn results in better
understanding and facilitating of decision making during the
cardiac catheterization procedures and cardiac surgery.
These systems generally acquire a volumetric data set,
which can then be displayed in custom orientations. The
technique captures 3D views of the heart structures with
greater depth than 2D echocardiography.4.3. M-mode echocardiographyM-mode can provide additional information for character-
izing the motion of cardiac structures. To ensure proper align-
ment and reproducibility, all M-mode recordings are performed
with 2D guidance. M-mode echo is useful for measuring heart
structures, such as the heart’s pumping chambers, the size of the
heart, and the thickness of the heart walls.4.4. Doppler echocardiography8This technique is used to measure and assess the flow of
blood through the heart’s chambers and valves. Doppler echo-
cardiography has the ability to estimate the pressure difference
across a stenotic valve (e.g., aortic stenosis) or between two
chambers (e.g., estimation of the pulmonary artery systolic
pressure from the tricuspid regurgitation velocity). The modi-
fied Bernoulli equation (Delta P ¼ 4*V2) is the most commonly
used application relating peak velocity to peak pressure
gradient. There are several Doppler methods used for cardiac
evaluation-continuous wave, pulsed wave, and color flow.4.5. Color Doppler8Color flow imaging is typically used in the screening and
assessment of regurgitant flows, intracardiac shunts, and pul-
monary vein flow. Different colors are used to designate the
direction of blood flow.
5. TEE in clinical applications5.1. Critical care21e24TEE can be performed quickly at the bedside in critically ill
patients with unexplained hypotension, unexplained hypox-
emia, uncertain volume status, and blunt chest trauma.
Fig. 1. (1) The mid-esophageal views of transesophageal echocardiography (TEE). (A) Four chamber view at 0 degrees; (B) five chamber view at 0 degrees; (C)
right ventricle (RV) inflow-outflow view at 80 degrees; (D) two chamber view at 90 degrees; (E) left ventricle (LV) long axis view at 120 degrees; and (F) bicaval
view at 90e120 degrees. (2) The upper-esophageal views of TEE. (A) main pulmonary artery (MPA); (B) right pulmonary artery (RPA); (C) left pulmonary artery
(LPA); and (D) ascending aorta (AAo). (3) The transgastric views of TEE. (A) short axis view for papillary muscle; (B) short axis view for mitral leaflet; and (C)
long axis view for chordae apparatus (arrow). AL ¼ anterolateral papillary muscle; Ao ¼ aorta; AV ¼ aortic valve; C ¼ central venous catheter; IVC ¼ inferior
vena cava; LA ¼ left atrium; LV ¼ left ventricle; PA ¼ pulmonary artery; PM ¼ posteromedial papillary muscle; PV ¼ pulmonary valve; RA ¼ right atrium;
RUPV ¼ right upper pulmonary vein; RV ¼ right ventricle; RVOT ¼ right ventricle outflow tract; SVC ¼ superior vena cava; VS ¼ ventricular septum.
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Fig. 2. (A) A case of left atrial myxoma (M) with obstruction of the left ventricle inflow and minimization of the flow (arrow) toward the left ventricle; (B) enface
left atrium view of real-time three-dimensional transesophageal echocardiography (TEE) shows a pedicle of the myxoma (arrow) attached to interatrial septum and
protruding through the mitral valve. Ao ¼ aorta; IAS ¼ interatrial septum; LA ¼ left atrium; LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle.
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Air embolism is an uncommon, but potentially catastrophic
complication. Venous air embolism complicates laparoscopic
procedures, orthopediatric, or neurosurgical procedures when-
ever the surgical incision site is above the level of the patient’s
heart, such that pressure in the veins is subatmospheric. TEE
may play an important role and is more sensitive for detecting
intracardiac air resulting from venous air embolism.
5.1.2. Pulmonary thromboembolism27,28
Pulmonary embolism (PE) is the third most common cardio-
vascular disease after myocardial infarction and stroke.
Approximately 90% of all pulmonary thromboemboli originate
from deep veins of the lower extremities. Deep venous throm-
bosis and PE constitute venous thromboembolism. Fortunately,
central pulmonary emboli are directly visualized with TEE.
TEE may play a primary role in patients who have suspected
massive emboli and are too unstable to transfer elsewhere for CT
imaging examination, or for ventilationeperfusion scanning.
5.1.3. Blunt chest trauma29
Blunt cardiac injury occurs most often from motor vehicle
collisions. Patients with clinical or echocardiographicFig. 3. (A) Two-dimensional (2D) transesophageal echocardiography (TEE) (apica
commissures and vegetation formation; (B) fish mouth shape of mitral valve orifice
prosthetic tissue mitral valve. Ao ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle.evidence of severe cardiac injury (e.g., ruptured valve, septum,
or ventricular wall; cardiac tamponade) require emergent
surgical consultation.
5.1.4. Penetrating injuries of the heart30
Penetrating injuries of the heart are caused by stab or
gunshot wounds, or the rare accidental impalement. Unlike
blunt cardiac injuries, the heart or great vessels should be
immediately suspected in any patient suffering from pene-
trating trauma of the chest. Most patients’ hemodynamics are
unstable in the field and many present to the emergency
department receiving cardiopulmonary resuscitation.
5.1.5. Cardiac arrest22,27
Management of the post-cardiac arrest patient is complex
and must address multiple major problems simultaneously.
TEE provides a clear view of cardiac wall motion abnormal-
ities, valvular or septal injuries, or pericardial disease.5.2. Cardiac surgeryIn surgical management, TEE can reveal new findings
that necessitate reconfirmation. It is indispensable to earlyl 4-chamber view) in a patient with rheumatic mitral stenosis shows fusion of
is delineated by 3D TEE enface LA view; and (C) mitral stenosis is replaced by
Fig. 4. Mitral regurgitation. (A) Four-chamber apical view of a two-dimensional (2D) transesophageal echocardiography (TEE) demonstrates anterior leaflet
prolapse with ruptured chordae (arrow); (B) color Doppler apical four-chamber view shows severe mitral regurgitation with the regurgitant jet hitting the distant
wall of the left atrium and encircling it, as well as traversing back into the pulmonary veins; (C) 3D TEE demonstrates the height of the A3 flail (arrow); (D)
prolapse of A3 is reconstructed mitral valve using Mitral Valve Quantification software (MVQ) (Advanced Quantification Software version 7.1, Philips Ultra-
sounds, Bothell, WA); and (E) surgeon’s view: A3 cord is visualized (arrow). Ao ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right
ventricle.
665S.-K. Tsai / Journal of the Chinese Medical Association 76 (2013) 661e672evaluation of inadequate surgical repair and reversion without
hesitation during adult and congenital heart surgery.
5.2.1. Adult cardiac surgery
In one prospective study of 474 consecutive patients un-
dergoing coronary artery surgery, TEE prompted a change in
the surgical plan in 3.4% of the patients.31 In the absence of
contraindications, TEE is indicated in virtually all cardiac
surgery, because it provides an assessment of the surgical
intervention in the operating room, where any neededFig. 5. Patient with aortic regurgitation with Austin Flint diastolic murmur. (A) long
of blood from the aorta presses on the anterior leaflet of the mitral valve (multiple a
of short axis demonstrates the regurgitant orifice on right and non-coronary cusp
(circle). Ao ¼ aorta; LA ¼ left atrium; MV ¼ mitral valve; RV ¼ right ventricle.procedural revisions can be accomplished immediately. In 205
consecutive patients undergoing posterior mitral leaflet
quadrangular resection (the most common mitral repair tech-
nique), TEE revealed failures in 24 patients (11%).32 In 20 of
these patients, TEE identified the mechanism of failure and
guided immediate further repair.
5.2.2. Atrial myxoma
Myxomas are the most common type of benign cardiac
primary tumors. They are usually located in the left atrium-axis view of transesophageal echocardiography (TEE) image shows backflow
rrows), producing functional mitral valve stenosis; (B) the corresponding view
id (arrow); and (C) three-dimensional TEE delineates the regurgitant orifice
Fig. 6. (1) Newborn infants with complex congenital heart diseases. (A) Two-dimensional (2D) echocardiogram (apical 4-chamber view) in an infant with tricuspid
atresia (TA) shows a complete absence of the tricuspid valve, right atrioventricular connection, and single ventricle; (B) four-chamber view in an infant with a
rhabdomyoma of the heart shows echogenic mass (T) attached to the interventricular septum and reducing the size of the outflow tract; (C) an infant with hy-
poplastic left heart syndrome demonstrates a hypoplastic aorta (Ao) and a huge pulmonary artery (PA); and (D) an infant with hemitruncus arteriosus shows the
right PA (RPA) originating from the ascending Ao (AAo) and the left PA (LPA) from the pulmonary artery (PA). (2) A newborn with transposition of great arteries
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mitral obstruction, systemic emboli, or life-threatening com-
plications, such as heart failure, syncope, or sudden death.
TEE is used to assess the location of tumor attachment and
measure the size of the mass to better facilitate surgeons as
they move to complete the operation.
5.2.3. MV diseases33e36
MV repair surgery has become more common in the last
decade, constituting more than half of MV procedures. Its
feasibility depends on the location, extent, and mechanism of
MV disease. Perioperative monitoring of MV anatomy, func-
tion, and pathology is essential for surgical management of
different MV disease. 3D TEE allows visualization of the
anatomic structure of the heart to be online and clearly iden-
tifies the valvular apparatus and its defects, which mimic
actual anatomy as viewed by the surgeons in situ. We conclude
that real-time 3D TEE should be regarded as an important
adjunct to the standard 2D TEE examination in making de-
cisions perioperatively.
5.2.3.1. Mitral stenosis. In mitral stenosis, the normal, rapid,
biphasic motion of the valve is altered, because the valve
opens only partly to a certain degree. TEE can identify the
pathologic entity of mitral stenosis and quantitate its severity
with sufficient accuracy to make reliable decisions (Fig. 3).
Doppler methods can measure the velocity of mitral inflow. In
mitral stenosis, this velocity increases at rest from a normal
value of <1 m/second to >1.5 m/second. The 2006 ACC/AHA
guidelines on valvular heart disease defined severe mitral
stenosis as having a mean transmitral gradient >10 mmHg,
pulmonary artery systolic pressure >50 mmHg, and an MVA
<1.0 cm2.
5.2.3.2. Mitral regurgitation. 2D TEE was routinely used for
planning of MV regurgitation surgery. However, in complex
valvular pathologies, 2D TEE has several potential pitfalls
with regard to spatial relationships and valvular morphological
abnormalities. In our previous study, real-time 3D/2D TEE
was used to assess 73 patients (44 men and 29 women) with
Carpentier type II MV regurgitation undergoing MV surgery
perioperatively. The isolated segment most frequently
involved was A2 or P2, but A1 or P1 rarely was involved in an
isolated lesion or combined with other lesions. The agreement
between 3D TEE finding and surgery was 88% (64/73)
(Fig. 4).33
In addition, retrograde systolic left atrial flow, caused by
the swirling of a large regurgitant eccentric jet, is commonly
noted in patients with a flail MV leaflet. 2D TEE color
Doppler is the most widely used method for assessing the
seriousness of mitral regurgitation (MR) and positioning the(TGA). TGA is usually detected within the first hours to weeks of life. (A) 2D transe
PA arises directly from the left-sided posterior left ventricle and the Ao arises d
abnormal crisscrossing of the Ao (anterior location) and PA (posterior location); (C
their correct places; and (D) the postoperative complication following arterial switch
atrium; LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle; SV ¼ singllesions. The severity of MR that produces eccentric rather than
central jet flows can be underestimated on 2D TEE Doppler
images. Moreover, it can often be challenging to identify
which mitral leaflet is affected via 2D TEE color Doppler in
patients with very eccentric MR jets. In contrast, RT 3D TEE
can provide a true cross-section view of the MV and is
therefore a powerful tool during surgical repair of the MV. In
our study of 168 MR patients, 25 patients (14.9%) had central
jets and 143 patients (85.1%) had eccentric jets. Among the
143 patients with eccentric jets, 47 patients (32.9%) had free-
standing eccentric MR jets, and 96 (67.1%) patients had very
eccentric jets. 3D TEE diagnosed the severity and location of
MR lesions correctly in all patients, unlike 2D TEE, which
significantly missed in nine patients (9.4%) having MR with
very eccentric jets, due to such highly turbulent MR flow
produced by very eccentric jets from one mitral leaflet lesion
and impinging on the opposite mitral leaflet lesion.15
Furthermore, prosthetic paravalvular regurgitant can result
in heart failure and hemolytic anemia. Echocardiography re-
mains the main modality for the diagnosis of prosthetic valve
dysfunction. 2D TEE represents only a slice through the car-
diac tissue, which resulted in the missing of significant find-
ings. However, real-time 3D TEE can provide a more accurate
assessment of the exact site and size of the leakage while
closing the defect or revision surgery.
5.2.4. Aortic valve diseases37
TEE has the potential to guide aortic valve surgery and
improve outcomes. Prior to aortic valve surgery, valvular pa-
thology and annular measurements can be accurately exam-
ined for correct prosthesis sizing by TEE (Fig. 5). When aortic
valve surgery is completed, thereby the TEE was used to
evaluate the proper prosthesis seating and identify any regur-
gitation leakage around the prosthesis.
M-mode echocardiography remains useful in capturing the
motion of the aortic valve; variations in motion patterns are
often useful in differentiating severe from mild aortic stenosis.
In the setting of a trileaflet aortic valve, aortic valve M-mode
excursion of at least 12 mm is generally not consistent with
severe aortic stenosis.
5.2.5. Congenital heart disease surgery38,39
Early neonatal repair of congenital heart diseases (CHD)
has become possible recently, due to improvement of surgical
techniques, cardiopulmonary bypass, and intraoperative TEE
monitor. Intraoperative TEE is routinely used during cardiac
surgery to improve the quality of surgical repair and poten-
tially reduce the morbidity and mortality. We reported that
intraoperative TEE reliably detected residual cardiac defects
in 12 (5.6%) of 256 consecutive neonates and infants under-
going complex congenital heart surgery (Fig. 6-1 and 2).sophageal echocardiography (TEE) at five-chamber view demonstrates that the
irectly from the right-sided anterior right ventricle; (B) color Doppler shows
) a newborn with an arterial switch operation putting the PA and Ao back into
surgery with window between Ao and left pulmonary artery (LPA). LA ¼ left
e ventricle.
Table 1
Congenital heart disease surgery and TEE monitored in 256 newborns and
infants (1996.8e1998.8).
No. of patients
operated on
Operations
revised no.
VSD 103 3
TOF 34 2
TGA/ASO 31 5
CAVSD 18 0
TAPVC 13 1
DORV 13 0
PA/IVS 9 0
HLHS 8 1
CoA/IAA 8 0
RAI/TAPVC 5 0
PAPVC 4 0
Truncus A. 3 1
ALCAPA 3 0
LPA sling/tracheal stenosis 3 0
RVOT tumor 1 0
256 13 (5.1%)
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atrioventricular septal defect (CAVSD), coarctation of aorta
(CoA), double outlet right ventricle (DORV), hypoplastic left
heart syndrome (HLHS), partial anomalous pulmonary venous
connection (PAPVC), total anomalous pulmonary venous
connection (TAPVC), tetralogy of Fallot (TOF), ventricular
septal defect (VSD), transposition of great arteries (TGA),
anomalous left coronary arising from pulmonary artery
(ALCAPA), truncus arteriosus (TA), and pulmonary atresia
with intact ventricular septum (PA/IVS).
In addition, TEE is useful to visualize the precise anatomy
of posterior cardiac structures, especially in pulmonary veins,
while these structures were deemed to be difficult to be
delineated by transthoracic echocardiography (TTE). Our
previous study showed that seven (3 in supracardiac, 1 in
intracardiac and 3 in infracardiac) of 31 infants with TAPVC
had residual anastomotic site stenosis diagnosed by TEE
following the primary repair, because Doppler ultrasound
showed the presence of turbulent flow with a high mean peak
flow velocity (>71 cm/second) at the anastomotic site.Fig. 7. (A) Two-dimensional (2D) transesophageal echocardiography (TEE) showe
type. Color Doppler flow image documented continuous left-to-right shunting from
PDA with the Amplatzer duct occlude (Occluder) in optimal position; and (C) rea
perspective.Moreover, early detection of pulmonary venous obstruction
by TEE provides the immediate management during heart40
and lung transplantation.415.3. Catheter interventionThe rapidly expanding role of TEE in the management of
heart disease includes guidance of interventional cardiac
catheterization procedures and monitoring of results.
5.3.1. Patent ductus arteriosus42
Patent ductus arteriosus (PDA) is the second most common
CHD. The ductus arteriosus (DA) is a fetal vascular connec-
tion between the main pulmonary artery and the aorta that
diverts blood away from the pulmonary bed. After delivery,
the DA undergoes active constriction and eventual oblitera-
tion. A PDA occurs when the DA fails to completely close
postnatally. The first successful application of a PDA trans-
catheter closure technique suitable for use in infants and
children was performed in 1977. Currently, transcatheter
closure of PDA using the new Amplatzer ductal occluder is an
easy and effective technique (Fig. 7). Moreover, it has even
been shown to be safe in the presence of a wide PDA. It is
particularly useful in symptomatic infants and small children
with relatively large PDA. Two-dimensional imaging may
provide important qualitative information regarding the he-
modynamic significance of a PDA.
5.3.2. Patent foramen ovale and atrial septal defect43e46
Patent foramen ovale (PFO) is a flap-like opening between
the atrial septa primum and secundum at the location of the
fossa ovalis after the age of persistence. Most patients with
isolated PFO are asymptomatic and receive no further treat-
ment. However, paradoxical embolism in relation to PFO may
cause transient ischemic attack or stroke. Percutaneous closure
of the PFO is a widely used procedure in patients with para-
doxical embolism (Fig. 8).
The use of TEE for guidance of transcatheter closure of
secundum-type atrial septal defect (ASD) is increasinglyd a large patent ductus arteriosus (PDA) (12-mm width) of the “window-like”
the aorta (Ao) into the left pulmonary artery (LPA); (B) transcatheter closure of
l-time 3D TEE documenting the occluder (*) inside the PDA from the aortic
Fig. 8. (A) Two-dimensional (2D) transesophageal echocardiography (TEE) view demonstrated a patent foramen ovale (PFO) (large arrow) and an atrial septal
defect (ASD) (small arrow); (B) a 24 mm Amplatzer PFO occluder device was implanted; and (C) 3D TEE demonstrated proper placement of the device with
adequate coverage of all rims of the interatrial septum. Ao ¼ aorta; D ¼ Amplatzer PFO occluder device; LA ¼ left atrium; RA ¼ right atrium.
669S.-K. Tsai / Journal of the Chinese Medical Association 76 (2013) 661e672becoming a routine monitor. For transcatheter closure of an
ASD, TEE provided visualization of the defect and its mar-
gins, to ascertain that the rims of the device were properly
aligned and well seated on both sides of the interatrial septum.
After release of the placed occluder device, TEE was used to
visualize the normal anatomically closed defect, and color
flow mapping was used to evaluate the presence and location
of any residual interatrial shunting, possible obstruction to the
systemic or pulmonary venous return, and impairment of
atrioventricular valves.
3D TEE displays the defect as a dynamic ASD structure,
the size and morphology of which changes with the cardiac
cycle, and its maximal diameter can be better appreciated
when the periphery of the defect is seen in en-face view. 3D
TEE was used for patient selection and guidance to trans-
catheter closure of ASDs. One can visualize both atrial discs
of the occluder device and their dynamic anatomic relation to
the adjacent cardiac structures (Fig. 8).
TEE imaging not only assists in the positioning of devices
and catheters, but reduces radiation exposure and contrast load
in these patients and provides immediate and continuous
assessment during cardiac catheterization procedures.
In 2008, 600 pediatric patients underwent transcatheter
closure of ASD to evaluate the safety and feasibility of
transcatheter closure of ASD. In addition, we assessed 124
consecutive patients with ASD (57 secundum-type, 67 with
attenuated anterosuperior rim) closed with Amplatzer Septal
occluder under TEE guidance. Our results show that the TEEFig. 9. (A) Two-dimensional (2D) transesophageal echocardiography (TEE) and c
Amplatzer PDA occluder was implanted on the membranous VSD; and (C) Am
D ¼ Amplatzer occluder device; LV ¼ left ventricle; RV ¼ right ventricle.was successful in depicting all four corners and corresponding
edges of each Amplatzer disc, as well as the septal rims of all
57 secundum-type ASDs.
5.3.3. Ventricular septal defect47
Transcatheter ventricular septal defect (VSD) closure is a
treatment option for isolated uncomplicated muscular VSDs,
and for certain membranous VSDs. Device closure of
muscular VSDs using an Amplatzer device has reported a very
high rate of success (Fig. 9).48 The success rate for percuta-
neous closure of membranous VSDs with Amplatzer devices
is also high, but a VSD location remote from the tricuspid and
aortic valves with an adequate rim have to be measured by the
TEE. A complete arteriovenous wire loop from the aorta to the
LV and VSD out into the RV was formed in order to guide the
delivery sheath into the VSD from the RV.
5.3.4. Ruptured sinus of valsalva aneurysm49
Traditionally, surgical repair has been the mainstay of
therapy. Percutaneous transcatheter closure of ruptured sinus
of valsalva aneurysm provides a safe alternative strategy to
surgery.
5.3.5. Percutaneous aortic balloon valvotomy
Calcific or degenerative aortic valve disease is considered
the most common valvular lesion encountered among elderly
patients. Critical AS is defined when the calculated effectiveolor Doppler images of membranous ventricular septal defect (VSD); (B) the
platzer muscular occluder was deployed on the muscular VSD. Ao ¼ aorta;
Fig. 10. (A) Long axis view of transesophageal echocardiography (TEE)
shows the catheter (arrow) passing through the stenotic aortic valve; (B) long
axis view of TEE confirms proper positioning of the balloon inflated (arrow);
and (C) transcatheter approach completion TEE of implanted prosthetic aortic
valve. Ao ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle.
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>5 m/second.
Percutaneous aortic balloon valvotomy is a procedure in
which a balloon is placed across the stenotic aortic valve and
inflated. This approach offers a means of symptomatic palli-
ation and prevents performance of aortic valve replacement in
serious comorbid patients, or as a bridge to transcatheter aortic
valve implantation (TAVI).
5.3.6. TAVI50
Treatment of severe aortic valve stenosis in high-risk pa-
tients with percutaneous implantation of stent prosthesis has
recently become feasible and is associated with a lower mor-
tality rate.
Aortic stenosis is one of the most common valve pathol-
ogies found in elder adults. Patients with advanced age and
multiple comorbidities, such as pulmonary, renal, or cerebro-
vascular dysfunctions and deconditioning, carry significant
operative risks. Percutaneous transcatheter aortic valve im-
plantation (Fig. 10) is an emerging and promising technique,
and may lower the risk in this subset of patients. One of the
most important elements of a successful TAVI is the proper
placement and subsequent deployment of the device, which
can be continuously monitored by the TEE. Incorrect place-
ment may result in device embolization distally into the aorta,
or proximally into the LV, causing hemodynamic instability.
Accurate measurement of the annulus diameter is crucial in
determining the appropriate valve prosthesis size. TEE plays
an important role in the evaluation of the eligibility of patients
for percutaneous transfemoral or transapical aortic valve
replacement. Correct sizing prevents device embolization and
minimizes the degree of paravalvular leak. During the proce-
dure, TEE assists in the advancement of guidewires and
delivering system and subsequently the valve prosthesis.
Complications such as aortic dissection, cardiac tamponade,
and device malpositioning can readily be diagnosed by
continuous TEE monitoring.
5.3.7. Transcatheter closure of mitral paravalvular
leakage51
Paravalvular leaks are well-known complications seen
following cardiac valve surgery. Paravalvular MR after MV
replacement may lead to heart failure, hemolysis, and unilat-
eral pulmonary edema. The use of percutaneous intervention
techniques with an occluder device for mitral prosthesis par-
avalvular leak has become an attractive alternative to surgical
repair. TEE is used to assess the location and severity of
paravalvular MR before percutaneous closure and to guide the
transapical puncture or retrograde approach (Fig. 11). When
the occluder device is deployed, the use of TEE helps to
confirm if it is seated on an appropriate position and the
prosthetic valve functions. Moreover, the utilization of com-
bined TEE and fluoroscopic guidance of interventional pro-
cedures can reduce the radiation exposure time.
In conclusion, in this article we describe the wide use of
TEE in common and standard procedures for cardiac patients.
The rapidly expanding role of TEE in the management of heartdisease includes acute ill patients for cardiac or non-cardiac
surgery, emergency medicine and guidance of interventional
cardiac catheterization procedures, and monitoring of results.
Recently, real-time 3D TEE allowed for online assessment of
cardiac structures and novel views of complex cardiac ab-
normalities in anatomy. Therefore, basic knowledge of cardiac
anatomy and pathophysiology is of paramount important for a
more complete understanding and wider use of TEE in clinical
Fig. 11. Transapical closure of mitral paravalvular leak. (A) Apical four chamber view of two-dimensional (2D) transesophageal echocardiography (TEE) shows a
paravalvular leak (arrow); (B) 3D TEE image of the mitral annulus and mechanical prosthesis en face from the left atrium in diastole. The paravalvular defect is
located along the anteromedial border of the prosthesis ring at 3 o’clock (arrow); (C) 3D TEE image of the mitral annulus and mechanical prosthesis en face from
the left atrium after introduction of a 10-mm Amplatzer muscular occluder device seated on the defect. Ao ¼ aorta; D ¼ Amplatzer occluder device; LA ¼ left
atrium; LV ¼ left ventricle; MV ¼ mitral valve.
671S.-K. Tsai / Journal of the Chinese Medical Association 76 (2013) 661e672management in patients with heart problems, to enhance the
efficiency and safety of these procedures.
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